The NSCLC therapeutics market is a rapidly evolving field in which new developments are constantly influencing the landscape. The Forecast Update is designed to help clients stay abreast of the latest news in the NSCLC space, including regulatory, commercial, and clinical events, and to understand how these events will impact the market forecast.
Scope
Key events covered in the Forecast Update include:
Regulatory filings
Approval decisions
Pricing changes
Patent litigation
Clinical trial data announcements
Clinical trial failures
Clinical trial timeline updates
The Forecast Update consists of a slide deck detailing key market-impacting events that have occurred since the last publication of the PharmaPoint: NSCLC report, along with an updated Excel-based forecast model which reflects the projected influence of these events on the future NSCLC market.
Components of the slide deck include:
Timeline of market-impacting events
Key clinical trial landscape updates
Detailed analysis of the most impactful events, including new primary research to gain Key Opinion Leader perspective
Overview of updates to the forecast model based on anticipated future impact of events
Forward-looking events calendar listing expected key updates to the NSCLC competitive space in the next quarter
Key Highlights
Updates in the NSCLC space since the last report including:
Recent regulatory events
Recent commercial events
Recent clinical events
Market dynamics in the frontline NSCLC setting
Landscape changes in the EGFR-mutant NSCLC setting
Projected treatment algorithm shifts in the ALK-mutant NSCLC setting
